Healthcare Global Enterprises Share Price
711.70+8.25 (+1.17%)
+3.15% past 1 Year
HealthCare Global Enterprises (HCG) is a leading healthcare provider in India dedicated to delivering patient-centric and personalized care for cancer and other health conditions. With over years of experience in
Corporate filings & documents
Announcements
Please note that letters are being dispatched to the Members of the Company containing web link and path of Integrated Annual Report for Financial Year 2025-26.
6 days agoPlease note that letters are being dispatched to the Members of the Company containing web link and path of Integrated Annual Report for Financial Year 2025-26.
6 days agoNewspaper advertisement pertaining to dispatch of 28th Annual General Meeting and Integrated Annual Report for FY 2025-26.
6 days agoNewspaper advertisement pertaining to dispatch of 28th Annual General Meeting and Integrated Annual Report for FY 2025-26.
6 days agoPlease find enclosed the Notice of 28th Annual General Meeting and Integrated Annual Report of the Company for FY 2025-26.
1 week agoPlease find enclosed the Notice of 28th Annual General Meeting and Integrated Annual Report of the Company for FY 2025-26.
1 week agoPlease find enclosed the Integrated Annual Report of the Company for FY 2025-26.
1 week agoPlease find enclosed the Integrated Annual Report of the Company for FY 2025-26.
1 week agoPlease find enclosed the Business Responsibility and Sustainability Report ("BRSR") of the Company for FY 2026.
1 week agoPlease find enclosed the Business Responsibility and Sustainability Report ("BRSR") of the Company for FY 2026.
1 week agoNewspaper advertisement pertaining to Notice of Annual General Meeting in accordance with MCA General Circular No. 20/2020 dated May 05 2020.
1 week agoNewspaper advertisement pertaining to Notice of Annual General Meeting in accordance with MCA General Circular No. 20/2020 dated May 05 2020.
1 week agoPlease find attached herewith the Transcript of Earnings Call held on August 07 2026 with Analysts/Investors to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
3 weeks agoPlease find attached herewith the Transcript of Earnings Call held on August 07 2026 with Analysts/Investors to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
3 weeks agoNewspaper Advertisement of Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026 approved at the meeting of Board of Directors held on August 06 2026.
3 weeks agoNewspaper Advertisement of Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026 approved at the meeting of Board of Directors held on August 06 2026.
3 weeks agoThis is to inform that the Company will be participating in the group investor meeting hosted by Ambit Capital in Bangalore.
3 weeks agoThis is to inform that the Company will be participating in the group investor meeting hosted by Ambit Capital in Bangalore.
3 weeks agoThis is to inform you that the Audio recording of the Earnings Call with Analysts/Investors held on August 07 2026 to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026 is made available on the website of the Company.
3 weeks agoThis is to inform you that the Audio recording of the Earnings Call with Analysts/Investors held on August 07 2026 to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026 is made available on the website of the Company.
3 weeks agoPress release on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
4 weeks agoPress release on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
4 weeks agoInvestor Presentation on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
4 weeks agoInvestor Presentation on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
4 weeks agoMonitoring Agency Report for the quarter ended June 30 2026 in relation to the Rights Issue of the Company..
4 weeks agoMonitoring Agency Report for the quarter ended June 30 2026 in relation to the Rights Issue of the Company..
4 weeks agoStatement of Variation or Deviation for funds raised through Rights Issue for the quarter ended June 30 2026.
4 weeks agoStatement of Variation or Deviation for funds raised through Rights Issue for the quarter ended June 30 2026.
4 weeks agoThe Board of Directors has approved the re-appointment of M/s Rao Murthy & Associates Cost Accountants as Cost Auditors of the Company for the financial year 2026-27.
4 weeks agoThe Board of Directors has approved the re-appointment of M/s Rao Murthy & Associates Cost Accountants as Cost Auditors of the Company for the financial year 2026-27.
4 weeks agoThe Board of Directors of the Company has approved a further investment of up to INR 16 Crores in HCG Rajkot Hospitals LLP a wholly-owned subsidiary of the Company.
4 weeks agoThe Board of Directors of the Company has approved a further investment of up to INR 16 Crores in HCG Rajkot Hospitals LLP a wholly-owned subsidiary of the Company.
4 weeks agoUnaudited Financial Results of the Company for the quarter ended June 30 2026.
4 weeks agoUnaudited Financial Results of the Company for the quarter ended June 30 2026.
4 weeks agoThe Company has announced the Outcome of the Board meeting held on August 06 2026 including approval of unaudited financial results of the Company for the quarter ended June 30 2026.
4 weeks agoThe Company has announced the Outcome of the Board meeting held on August 06 2026 including approval of unaudited financial results of the Company for the quarter ended June 30 2026.
4 weeks agoPursuant to Regulation 30 of LODR we would like to inform that HCG Manavata Oncology LLP a subsidiary LLP of the Company has entered into agreement to acquire 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited (EVRE) through subscription of equity shares for an aggregate consideration of INR 38 Lakhs to qualify as a captive user of the power plant operated by EVRE.
1 month agoPursuant to Regulation 30 of LODR we would like to inform that HCG Manavata Oncology LLP a subsidiary LLP of the Company has entered into agreement to acquire 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited (EVRE) through subscription of equity shares for an aggregate consideration of INR 38 Lakhs to qualify as a captive user of the power plant operated by EVRE.
1 month agoFurther to the intimation submitted to Stock Exchanges dated July 27 2026 with respect to the meeting of the Board of Directors of the Company to be held on Thursday August 06 2026 inter-alia to consider approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter ended June 30 2026 (Financial Results) we would like to inform you that an Earnings Conference Call has been scheduledon Friday August 07 2026 at 02.00 p.m. (IST) to discuss the Financial Results of the Company.
1 month agoFurther to the intimation submitted to Stock Exchanges dated July 27 2026 with respect to the meeting of the Board of Directors of the Company to be held on Thursday August 06 2026 inter-alia to consider approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter ended June 30 2026 (Financial Results) we would like to inform you that an Earnings Conference Call has been scheduledon Friday August 07 2026 at 02.00 p.m. (IST) to discuss the Financial Results of the Company.
1 month agoHealthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve the Unaudited Financial Results (Both Standalone And Consolidated) of the Company for the quarter ended June 30 2026 (Financial Results).
1 month agoHealthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve the Unaudited Financial Results (Both Standalone And Consolidated) of the Company for the quarter ended June 30 2026 (Financial Results).
1 month agoNewspaper Advertisement in respect of Special Window for Transfer and Dematerialisation of Physical Securities of the Company.
1 month agoNewspaper Advertisement in respect of Special Window for Transfer and Dematerialisation of Physical Securities of the Company.
1 month agoScrutinizers report and Outcome of the Postal Ballot for the agenda(s) listed in the Postal Ballot Notice dated June 08 2026 of the Company.
1 month agoScrutinizers report and Outcome of the Postal Ballot for the agenda(s) listed in the Postal Ballot Notice dated June 08 2026 of the Company.
1 month agoCertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026.
2 months agoCertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026.
2 months agoIntimation for closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations 2015 for the quarter ending June 30 2026.
2 months agoIntimation for closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations 2015 for the quarter ending June 30 2026.
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Dec 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Jun 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-03-02
Rights
1:17;512.0 (Rights ratio;Offer price)
Company details
Registered office
H C G Tower, No.8 P. Kalinga Rao Road Sampangi Rama Nagar Bengaluru Karnataka PIN: 560027 Tel No: 080 - 33669999 Fax No: NULL Email: [email protected] Internet: www.hcgoncology.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Sunu Manuel, Company Secretary & Compliance Officer
Manish Mattoo, Whole Time Director & Chief Executive Officer
B S Ajai Kumar, Chairman
Anjali Rossi Ajaikumar, Non Independent & Non Executive Director
Simrun Mehta, Non Independent & Non Executive Director
Akshay Tanna, Non Independent & Non Executive Director
Rajagopalan Raghavan, Non Executive Independent Director
Geeta Mathur, Non Executive Independent Director
Pradip Kanakia, Non Executive Independent Director
Rajiv Maliwal, Non Executive Independent Director
Bijou Kurien, Non Executive Independent Director
Details
BSE 539787
NSE HCG
ISIN INE075I01017